-
Signature
-
/s/ Karole Morgan-Prager, Attorney-in-Fact
-
Issuer symbol
-
BL
-
Transactions as of
-
30 Sep 2024
-
Net transactions value
-
-$3,483,559
-
Form type
-
4
-
Filing time
-
01 Oct 2024, 19:37:23 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BL |
Common Stock |
Options Exercise |
$555,002 |
+39,643 |
+17% |
$14.00 |
266,487 |
30 Sep 2024 |
Direct |
F1 |
| transaction |
BL |
Common Stock |
Options Exercise |
$639,310 |
+45,665 |
+17% |
$14.00 |
312,152 |
30 Sep 2024 |
Direct |
F1 |
| transaction |
BL |
Common Stock |
Sale |
$781,727 |
-14,423 |
-4.6% |
$54.20 |
297,729 |
30 Sep 2024 |
Direct |
F1, F2 |
| transaction |
BL |
Common Stock |
Sale |
$3,736,613 |
-68,025 |
-23% |
$54.93 |
229,704 |
30 Sep 2024 |
Direct |
F1, F3 |
| transaction |
BL |
Common Stock |
Sale |
$159,531 |
-2,860 |
-1.2% |
$55.78 |
226,844 |
30 Sep 2024 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
BL |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-39,643 |
-100% |
$0.000000 |
0 |
30 Sep 2024 |
Common Stock |
39,643 |
$14.00 |
Direct |
F1, F5 |
| transaction |
BL |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-45,665 |
-100% |
$0.000000 |
0 |
30 Sep 2024 |
Common Stock |
45,665 |
$14.00 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: